Daphne Lainson presents ‘Preparing for PMPRB Final Guidelines’ at the Pathways to Access & Reimbursement virtual conference

Ottawa partner Daphne Lainson will present the at the Pathways to Access & Reimbursement virtual conference, presented by the Canadian Institute, on Thursday, January 21, 2021.

Daphne’s session—Preparing for PMPRB Final Guidelines: An Examination of the Practical Impact on Drug Pricing in Canada—will cover analysis of the final PMPRB guidelines, from revised reference countries to the use of pharmacoeconomics; how to conduct an impact analysis on grandfathered products, line extensions, gap medicines and new medicines; and will discuss how to assess and manage cross-border market access issues.

This year’s virtual conference re-imagines the forum of a live in-person event to an interactive virtual format, designed to bring clarity to some of the greatest challenges facing manufacturers, patients, and payers alike in a radically altered healthcare climate. Attendees will receive information on drug reviews and pricing ceilings, gain insights on reimbursement regimes, understand how to bring innovative solutions to market, hear about how other jurisdictions are approaching HTA and pricing negotiations and learn about developments in precision medicine.

Smart & Biggar is widely recognized as Canada’s leading firm for intellectual property law, with offices in Ottawa, Toronto, Montreal, Vancouver and Calgary. We are leaders in intellectual property and technology law and have been serving clients for over a century.